Celebrating 20 Years of Honoring the Digital Breakthroughs, Pioneering Startups, and Ecosystems Driving the Future of Healthcare
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, announced today the 2026 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup." Winners will be honored during the Prix Galien USA Awards Ceremony on October 29, 2026, at the American Museum of Natural History in New York City.
"Witnessing the incredible momentum in medical technology, digital health, and startup ventures is inspiring," said Kenneth C. Frazier, Co-Chair of the Galien Forum, Prix Galien USA Awards Committee. "As we celebrate two decades of the Prix Galien USA Awards, we look forward to honoring this new class of nominees whose inventive work epitomizes the future of health and our collective commitment to improving lives through scientific brilliance."
Marking two decades of shaping medicine for patients worldwide, The Galien Foundation continues to inspire spirited collaboration between science and industry leaders on the most critical topics in medical technology, entrepreneurship, and equity.
"We applaud this year's remarkable Prix Galien USA nominees as we mark twenty years of excellence in medical technology, digital health, and entrepreneurship," said Bruno Cohen, Chairman of The Galien Foundation. "Their achievements beautifully demonstrate how scientific advancements can transform human lives and improve the wellbeing of our planet."
To qualify, each candidate must demonstrate tremendous potential to improve human health and for "Best Medical Technology" must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.
The following candidates have been selected as the 2026 Prix Galien USA nominees:
Best Digital Health Solution (Nominees)
Accumulus Technologies
Accumulus Platform
AEYE Health
AEYE-DS (AEYE Diagnostic Screening)
Altis Labs, Inc.
Imaging-based Prognostication (IPRO)
Aptar Digital Health
Migraine Buddy: a digital health solution generating insights from user-reported data and continuous biometrics
Ayble Health
Ayble: AI-Enabled Virtual Specialty GI Clinic
Beaconcure
Verify: AI-Enabled Statistical Analysis Platform
Biorce
Aika
Cleerly
Cleerly LABS
Evidation Health
Event-Triggered Flare-State Proteomics Platform and Autoimmune Cohort
Evinova
Unified Trial Solution
Fasikl
Felix NeuroAI Wristband
Gheorg
Mental Health App Democratizing Therapy Support for Children
Helfie AI
Helfie AI
Intellect
Intellect: Clinically Validated AI-enabled Global Mental Healthcare Platform
Life365
CloudCare
Medable
Medable Agentic Clinical Development Platform
MPA
MyPsychAdmin
OpenEvidence Inc.
OpenEvidence
Owkin
K Pro
PHIL Inc.
PHIL Digital Hub & PHIL Direct
RapidAI
Rapid Navigator Pro™
SamaCare
SamaCare Platform
The TeleDentists
The TeleDentists
Welldoc
The Welldoc Platform: Healthcare-Ready AI
Best Medical Technology (Nominees)
Abbott
AVEIR™ Dual Chamber (DR) Leadless Pacemaker System
Abbott
Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
Abbott
TriClip™ G4 System
Alcon
UNITY® Vitreoretinal Cataract System (VCS)
Beyond Air, Inc.
LungFit® PH
Cochlear Limited (Cochlear North America)
Nucleus® Nexa™ System
Cresilon
TRAUMAGEL®
Edwards Lifesciences
Edwards SAPIEN M3 Transcatheter Mitral Valve Replacement System
Establishment Labs Holdings Inc.
Motiva Flora® SmoothSilk® Tissue Expander
Guardant Health
Guardant360® Liquid CDx
Guardant Health
Shield™
Insightec
Exablate® Neuro
Johnson & Johnson
INLEXZO™ (gemcitabine intravesical system)
Johnson & Johnson
Impella 5.5™ with SmartAssist™; Impella CP™ with SmartAssist™
Johnson & Johnson
Shockwave™ C2 Coronary IVL Catheter
Lumicell
LumiSystem™
Lungpacer Medical
AeroPace® Transvenous Diaphragm Neurostimulation System
MediBeacon Inc.
TGFR™ System
Medtronic
Altaviva™ Implantable Tibial Neuromodulation Device
Medtronic
Symplicity Spyral™ Renal Denervation System
MiniMed
MiniMed Go™ System
OUR United Corporation
TaiChiPro®
RefleXion Medical
RefleXion® X1 with SCINTIX® biology-guided radiotherapy
Incubators, Accelerators and Equity (Nominees)
ANDHealth (Australia)
ANDHealth+
Avant Bio
Avant Bio Fund II LP
Calibr-Skaggs Institute for Innovative Medicines
Calibr-Skaggs Drug Accelerator
Cross-Border Impact Ventures
Women's and Children's Health Technology Fund
Deep Knowledge Group (incorporating Deep Knowledge Ventures, Longevity Capital, Deep Knowledge Analytics, Deep Pharma Intelligence and Aging Analytics Agency) (https://www.dkv.global/)
Deep Knowledge Group - DeepTech for Social Good (investment, analytics and ecosystem-building consortium spanning AI, Longevity, BioTech and HealthTech)
Mayo Clinic
Mayo Clinic / Mayo Clinic and Arizona State University Alliance for Health Care Accelerator
McGill Dobson Centre for Entrepreneurship
McGill Dobson Centre for Entrepreneurship
Nucleate
The Activator
PureTech Health
PureTech Health
Start it @KBC
Start it @KBC
Weill Cornell Medicine BioVenture Elab
BioVenture eLab
Best Startup (Nominees)
ADVANCED BIODESIGN
AIVITA Biomedical, Inc.
Algen Biotechnologies, Inc.
Alloy Therapeutics
BigHat Biosciences
Bilix
BioSapien
Callio Therapeutics
Captor Therapeutics
Cellares
CheckUps COVA
Compass Pathways
Concordare Trials
Creative BioTherapeutics
EndoCyclic Therapeutics
EnPlusOne Bio
Faeth Therapeutics
General Oncology
HarborSite
Hemab Therapeutics (Nasdaq: COAG)
Hope Medicine
Iambic
Imaginostics, Inc.
Indapta Therapeutics
INGENIA Therapeutics Inc.
Innorna
Innova Therapeutics
Insilico Medicine
Intrepid Labs
Kapsule
LEAF4Life, Inc.
Leal Therapeutics
Leman Biotech Co., Ltd.
Libera Bio S.L.
LIFEN RESEARCH
Lipidio Pharma
magAssist Co., Ltd.
MAIA Biotechnology, Inc.
Mammoth Biosciences, Inc.
March Biosciences, Inc
Matrisome Bio, Inc.
Mesentech Inc.
META Pharmaceuticals Inc
Metro International Biotech, LLC
MirimGENE
Neurosterix
Noetik
Nona Biosciences
OncoRes Medical Pty Ltd
Outcomes4Me
OverT Bio
Paradigm Therapeutics
Pheast Therapeutics
Prellis Biologics, Inc
ProFound Therapeutics
Protara Therapeutics
Quercis
Regard
Rejuvenate Bio
Repair Biotechnologies, Inc.
ReST Therapeutics, Inc
RISA Labs
Rubedo Life Sciences, Inc.
SandboxAQ
Science Corporation
Sculpta, Inc.
SEED Therapeutics Inc.
Shenzhen ReeToo Biotechnology Co., Ltd.
Spore.Bio
Starton Therapeutics
Strand Therapeutics
Stream Biomedical, Inc.
SURGE Therapeutics
synseer
Tahoe Therapeutics
Transcend Therapeutics
Turbine
Ultrasound AI, Inc.
VarmX
Vascarta Inc.
VCCT Inc.
ViCardia Therapeutics, Inc.
XaTek Inc.
Zucara Therapeutics Inc.
Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2026
Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck
Roch DOLIVEUX
Honorary CEO, UCB
Dr. Mikael DOLSTEN
Former Chief Scientific Officer & President, Pfizer Research and Development
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
M.D., Global Head, Office of the Chief Medical Officer, Johnson & Johnson
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Christophe WEBER,
Healthcare Executive, Former CEO Takeda Pharmaceutical
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives. Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
Today, the Prix Galien operates through 16 chapters spanning more than 75 countries across Africa, the Americas, Asia, and Europe. Expansion is currently underway in China, Singapore, and Australia.
In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.
The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognizes up to three individuals for specific discoveries, the Prix Galien honors the collaborative spirit and multidisciplinary progress that define modern biopharmaceutical innovation.
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243
SOURCE The Galien Foundation
